Neuronetics, Inc. (STIM) income statement
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$1.25−0.03 (-2.34%)
Close on Nov 18, 2026Market cap $95.25MP/E –Yield –
Neuronetics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 49.1%
- Operating margin
- -14.7%
- Net margin
- -19.6%
- Return on equity, FY2025
- -155.7%
Financial strength
- Current ratio
- 1.88
- Debt to equity
- 3.45
- Debt to assets
- 46.8%
- Cash to current liabilities
- 67.8%
Valuation
- P/E ratio
- –
- Price to sales
- 0.61
- Price to book
- 5.34
- Dividend yield
- –
See a number that looks wrong?